Nite Thru
Natural health product licensed in Canada
- Other names
- Nite Thru Advanced Sleep Aid
- Licence holder
- Strides Global Consumer Healthcare Ltd
- NPN or DIN-HM
- 80081778
- Status
- Active licence
- Licence date
- 11 December 2017
- Revision date
- 11 June 2021
- Form
- Capsule, libération-retardée
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 10 milligramme | Not calculated |
Non-medicinal ingredients
Shellac, Acide stéarique, Bleu FD&C # 1, Phosphate dicalcique, Amidon de maïs, Rouge FD&C N° 40, Sucre, Dioxyde de titane, Colloidal silicon dioxide, Talc, Cellulose microcristalline, Polyvinylpyrrolidone, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps increase the total sleep time in people suffering from sleep restriction or altered sleep schedule. Helps to prevent and/or reduce the effects of jet lag. Helps to prevent and/or reduce the effects of daytime fatigue, sleep disturbance for people travelling by plane. across two or more time zones. Helps to reduce the time it takes to fall asleep in people with delayed sleep phase disorder Helps re-set the body's sleep-wake cycle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Nausea, vomiting, or cramping & rare allergic reactions have been known to occur in which case, discontinue use.
- Contre-indications
If you are pregnant or breast-feeding, do not use this product.
- Précautions et mises en garde
Consumption with alcohol, other medications or natural health products with sedative properties is not recommended Consult a health care practitioner prior to use if: you are taking anticoagulant, anticonvulsant, blood pressure, immunosuppressive, sedative, hypnotic or psychotropic medications, or steroids; you have asthma, cardiovascular disease, liver or kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, migraine, or seizure disorders.
Source
Official Health Canada record, licence 80081778
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging